Clinical trial NCT03543566 - References

Fecal Incontinence — Bladder Antimuscarinic Medication and Accidental Bowel Leakage

Citation(s)

•   Abrams P, Andersson KE, Birder L, Brubaker L, Cardozo L, Chapple C, Cottenden A, Davila W, de Ridder D, Dmochowski R, Drake M, Dubeau C, Fry C, Hanno P, Smith JH, Herschorn S, Hosker G, Kelleher C, Koelbl H, Khoury S, Madoff R, Milsom I, Moore K, Newman D, Nitti V, Norton C, Nygaard I, Payne C, Smith A, Staskin D, Tekgul S, Thuroff J, Tubaro A, Vodusek D, Wein A, Wyndaele JJ; Members of Committees; Fourth International Consultation on Incontinence
  Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn. 2010;29(1):213-40. doi: 10.1002/nau.20870. Review.
•   Bharucha AE, Zinsmeister AR, Schleck CD, Melton LJ 3rd
  Bowel disturbances are the most important risk factors for late onset fecal incontinence: a population-based case-control study in women. Gastroenterology. 2010 Nov;139(5):1559-66. doi: 10.1053/j.gastro.2010.07.056. Epub 2010 Aug 10.
•   Bliss DZ, Savik K, Jung HJ, Whitebird R, Lowry A, Sheng X
  Dietary fiber supplementation for fecal incontinence: a randomized clinical trial. Res Nurs Health. 2014 Oct;37(5):367-78. doi: 10.1002/nur.21616. Epub 2014 Aug 23.
•   Bols EM, Hendriks EJ, Deutekom M, Berghmans BC, Baeten CG, de Bie RA
  Inconclusive psychometric properties of the Vaizey score in fecally incontinent patients: a prospective cohort study. Neurourol Urodyn. 2010 Mar;29(3):370-7. doi: 10.1002/nau.20758.
•   Brown HW, Wexner SD, Segall MM, Brezoczky KL, Lukacz ES
  Quality of life impact in women with accidental bowel leakage. Int J Clin Pract. 2012 Nov;66(11):1109-16. doi: 10.1111/ijcp.12017.
•   Bulchandani S, Toozs-Hobson P, Parsons M, McCooty S, Perkins K, Latthe P
  Effect of anticholinergics on the overactive bladder and bowel domain of the electronic personal assessment questionnaire (ePAQ). Int Urogynecol J. 2015 Apr;26(4):533-7. doi: 10.1007/s00192-014-2527-2. Epub 2014 Oct 17.
•   Chapple C, Steers W, Norton P, Millard R, Kralidis G, Glavind K, Abrams P
  A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder. BJU Int. 2005 May;95(7):993-1001.
•   Coyne KS, Cash B, Kopp Z, Gelhorn H, Milsom I, Berriman S, Vats V, Khullar V
  The prevalence of chronic constipation and faecal incontinence among men and women with symptoms of overactive bladder. BJU Int. 2011 Jan;107(2):254-61. doi: 10.1111/j.1464-410X.2010.09446.x.
•   Darkow T, Fontes CL, Williamson TE
  Costs associated with the management of overactive bladder and related comorbidities. Pharmacotherapy. 2005 Apr;25(4):511-9.
•   Devroede G, Giese C, Wexner SD, Mellgren A, Coller JA, Madoff RD, Hull T, Stromberg K, Iyer S; SNS Study Group
  Quality of life is markedly improved in patients with fecal incontinence after sacral nerve stimulation. Female Pelvic Med Reconstr Surg. 2012 Mar-Apr;18(2):103-12. doi: 10.1097/SPV.0b013e3182486e60.
•   Ehrenpreis ED, Chang D, Eichenwald E
  Pharmacotherapy for fecal incontinence: a review. Dis Colon Rectum. 2007 May;50(5):641-9. Review.
•   Eric Jelovsek J, Markland AD, Whitehead WE, Barber MD, Newman DK, Rogers RG, Dyer K, Visco A, Sung VW, Sutkin G, Meikle SF, Gantz MG; Pelvic Floor Disorders Network
  Controlling anal incontinence in women by performing anal exercises with biofeedback or loperamide (CAPABLe) trial: Design and methods. Contemp Clin Trials. 2015 Sep;44:164-174. doi: 10.1016/j.cct.2015.08.009. Epub 2015 Aug 18.
•   Freeman A, Menees S
  Fecal Incontinence and Pelvic Floor Dysfunction in Women: A Review. Gastroenterol Clin North Am. 2016 Jun;45(2):217-37. doi: 10.1016/j.gtc.2016.02.002. Review.
•   Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ, Das AK, Foster HE Jr, Scarpero HM, Tessier CD, Vasavada SP; American Urological Association; Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction
  Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol. 2012 Dec;188(6 Suppl):2455-63. doi: 10.1016/j.juro.2012.09.079. Epub 2012 Oct 24.
•   Gormley EA, Lightner DJ, Faraday M, Vasavada SP; American Urological Association; Society of Urodynamics, Female Pelvic Medicine
  Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol. 2015 May;193(5):1572-80. doi: 10.1016/j.juro.2015.01.087. Epub 2015 Jan 23. Review.
•   Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, Coyne K, Kelleher C, Hampel C, Artibani W, Abrams P
  Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006 Dec;50(6):1306-14; discussion 1314-5. Epub 2006 Oct 2.
•   Jelovsek JE, Chen Z, Markland AD, Brubaker L, Dyer KY, Meikle S, Rahn DD, Siddiqui NY, Tuteja A, Barber MD
  Minimum important differences for scales assessing symptom severity and quality of life in patients with fecal incontinence. Female Pelvic Med Reconstr Surg. 2014 Nov-Dec;20(6):342-8. doi: 10.1097/SPV.0000000000000078.
•   Kannan H, Radican L, Turpin RS, Bolge SC
  Burden of illness associated with lower urinary tract symptoms including overactive bladder/urinary incontinence. Urology. 2009 Jul;74(1):34-8. doi: 10.1016/j.urology.2008.12.077. Epub 2009 May 9.
•   Kaplan SA, Dmochowski R, Cash BD, Kopp ZS, Berriman SJ, Khullar V
  Systematic review of the relationship between bladder and bowel function: implications for patient management. Int J Clin Pract. 2013 Mar;67(3):205-16. doi: 10.1111/ijcp.12028. Review.
•   Khullar V, Damiano R, Toozs-Hobson P, Cardozo L
  Prevalence of faecal incontinence among women with urinary incontinence. Br J Obstet Gynaecol. 1998 Nov;105(11):1211-3.
•   Lacima G, Espuña M, Pera M, Puig-Clota M, Quintó L, García-Valdecasas JC
  Clinical, urodynamic, and manometric findings in women with combined fecal and urinary incontinence. Neurourol Urodyn. 2002;21(5):464-9.
•   Lawrence JM, Lukacz ES, Nager CW, Hsu JW, Luber KM
  Prevalence and co-occurrence of pelvic floor disorders in community-dwelling women. Obstet Gynecol. 2008 Mar;111(3):678-85. doi: 10.1097/AOG.0b013e3181660c1b.
•   Leroi AM
  The role of sacral neuromodulation in double incontinence. Colorectal Dis. 2011 Mar;13 Suppl 2:15-8. doi: 10.1111/j.1463-1318.2010.02520.x. Review.
•   Lucak S, Chang L, Halpert A, Harris LA
  Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice. Therap Adv Gastroenterol. 2017 Feb;10(2):253-275. doi: 10.1177/1756283X16663396. Epub 2016 Sep 16. Review.
•   Markland AD, Burgio KL, Whitehead WE, Richter HE, Wilcox CM, Redden DT, Beasley TM, Goode PS
  Loperamide Versus Psyllium Fiber for Treatment of Fecal Incontinence: The Fecal Incontinence Prescription (Rx) Management (FIRM) Randomized Clinical Trial. Dis Colon Rectum. 2015 Oct;58(10):983-93. doi: 10.1097/DCR.0000000000000442.
•   Markland AD, Goode PS, Burgio KL, Redden DT, Richter HE, Sawyer P, Allman RM
  Correlates of urinary, fecal, and dual incontinence in older African-American and white men and women. J Am Geriatr Soc. 2008 Feb;56(2):285-90. Epub 2007 Dec 7.
•   Markland AD, Goode PS, Burgio KL, Redden DT, Richter HE, Sawyer P, Allman RM
  Incidence and risk factors for fecal incontinence in black and white older adults: a population-based study. J Am Geriatr Soc. 2010 Jul;58(7):1341-6. doi: 10.1111/j.1532-5415.2010.02908.x. Epub 2010 Jun 1.
•   Markland AD, Richter HE, Burgio KL, Wheeler TL 2nd, Redden DT, Goode PS
  Outcomes of combination treatment of fecal incontinence in women. Am J Obstet Gynecol. 2008 Dec;199(6):699.e1-7. doi: 10.1016/j.ajog.2008.08.035.
•   Markland AD, Richter HE, Kenton KS, Wai C, Nager CW, Kraus SR, Xu Y, Tennstedt SL; Urinary Incontinence Treatment Network
  Associated factors and the impact of fecal incontinence in women with urge urinary incontinence: from the Urinary Incontinence Treatment Network's Behavior Enhances Drug Reduction of Incontinence study. Am J Obstet Gynecol. 2009 Apr;200(4):424.e1-8. doi: 10.1016/j.ajog.2008.11.023. Epub 2009 Feb 6.
•   Meek PD, Evang SD, Tadrous M, Roux-Lirange D, Triller DM, Gumustop B
  Overactive bladder drugs and constipation: a meta-analysis of randomized, placebo-controlled trials. Dig Dis Sci. 2011 Jan;56(1):7-18. doi: 10.1007/s10620-010-1313-3. Epub 2010 Jul 2. Review.
•   Milsom I, Abrams P, Cardozo L, Roberts RG, Thüroff J, Wein AJ
  How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001 Jun;87(9):760-6. Erratum in: BJU Int 2001 Nov;88(7):807.
•   Santoro GA, Eitan BZ, Pryde A, Bartolo DC
  Open study of low-dose amitriptyline in the treatment of patients with idiopathic fecal incontinence. Dis Colon Rectum. 2000 Dec;43(12):1676-81; discussion 1681-2.
•   Smith TM, Menees SB, Xu X, Saad RJ, Chey WD, Fenner DE
  Factors associated with quality of life among women with fecal incontinence. Int Urogynecol J. 2013 Mar;24(3):493-9. doi: 10.1007/s00192-012-1889-6. Epub 2012 Jul 18.
•   Soligo M, Salvatore S, Milani R, Lalia M, Malberti S, Digesu GA, Mariani S
  Double incontinence in urogynecologic practice: a new insight. Am J Obstet Gynecol. 2003 Aug;189(2):438-43.
•   Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, Hunt TL, Wein AJ
  Prevalence and burden of overactive bladder in the United States. World J Urol. 2003 May;20(6):327-36. Epub 2002 Nov 15.
•   Vaizey CJ, Carapeti E, Cahill JA, Kamm MA
  Prospective comparison of faecal incontinence grading systems. Gut. 1999 Jan;44(1):77-80.
•   Wang JY, Abbas MA
  Current management of fecal incontinence. Perm J. 2013 Summer;17(3):65-73. doi: 10.7812/TPP/12-064. Review.
•   Whitehead WE, Borrud L, Goode PS, Meikle S, Mueller ER, Tuteja A, Weidner A, Weinstein M, Ye W; Pelvic Floor Disorders Network
  Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterology. 2009 Aug;137(2):512-7, 517.e1-2. doi: 10.1053/j.gastro.2009.04.054. Epub 2009 May 4.
•   Wu JM, Hundley AF, Fulton RG, Myers ER
  Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050. Obstet Gynecol. 2009 Dec;114(6):1278-83. doi: 10.1097/AOG.0b013e3181c2ce96.

Antimuscarinic Medication for Urgency Urinary Incontinence in Women With Dual Incontinence (Darifenacin for Treatment of Women With Dual Incontinence)

Details for clinical trial NCT03543566